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Development and validation of a risk calculator for
prediction of mortality after infrainguinal
bypass surgery
Prateek K. Gupta, MD,a Bala Ramanan, MBBS,a Thomas G. Lynch, MD,b
Abhishek Sundaram, MBBS, MPH,a Jason N. MacTaggart, MD,b Himani Gupta, MD,c
Xiang Fang, PhD,d and Iraklis I. Pipinos, MD,b Omaha, Neb
Objective: For peripheral arterial disease, infrainguinal bypass grafting (BPG) carries a higher perioperative risk compared
with peripheral endovascular procedures. The choice between the open and endovascular therapies is to an extent
dependent on the expected periprocedural risk associated with each. Tools for estimating the periprocedural risk in
patients undergoing BPG have not been reported in the literature. The objective of this study was to develop and validate
a calculator to estimate the risk of perioperative mortality <30 days of elective BPG.
Methods:We identified 9556 patients (63.9%men) who underwent elective BPG from the 2007 to 2009National Surgical
Quality Improvement Program data sets. Multivariable logistic regression analysis was performed to identify risk factors
associated with 30-day perioperative mortality. Bootstrapping was used for internal validation. The risk factors were
subsequently used to develop a risk calculator.
Results: Patients had a median age of 68 years. The 30-day mortality rate was 1.8% (n  170). Multivariable logistic
regression analysis identified seven preoperative predictors of 30-day mortality: increasing age, systemic inflammatory
response syndrome, chronic corticosteroid use, chronic obstructive pulmonary disease, dependent functional status,
dialysis dependence, and lower extremity rest pain. Bootstrapping was used for internal validation. The model
demonstrated excellent discrimination (C statistic, 0.81; bias-corrected C statistic, 0.81) and calibration. The validated
risk model was used to develop an interactive risk calculator using the logistic regression equation.
Conclusions: The validated risk calculator has excellent predictive ability for 30-day mortality in a patient after an elective
BPG. It is anticipated to aid in surgical decision making, informed patient consent, preoperative optimization, and
consequently, risk reduction. (J Vasc Surg 2012;56:372-9.)
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aOpen infrainguinal bypass grafting (BPG) surgery has
long been considered the gold standard surgical interven-
tion for lower extremity peripheral arterial disease (PAD).
However, during the last decade, there has been increasing
use of endovascular therapy for PAD.1 Although the latter
is favored when possible due to better short-term out-
comes, BPG is still indicated for certain anatomic consid-
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372rations and in patients with a life expectancy of2 years.1
he surgical decision-making process in patients who are
andidates for both open and endovascular therapy is based
n knowledge of the patients’ perioperative risks and ex-
ected life expectancy. Although the Edifoligide for the
revention of Infrainguinal Vein Graft Failure (PREVENT
II [PIII]) risk score2,3 and the Bypass Versus Angioplasty
n Severe Ischaemia of the Leg (BASIL) prediction model4
elp in assessing long-term amputation-free survival (AFS),
o the best of our knowledge, no reports of risk assessment
ools to estimate short-term perioperative outcomes asso-
iated with BPG have been published.
To address this issue, we reviewed the American College
f Surgeons’ (ACS) National Surgical Quality Improvement
rogram (NSQIP). Our objective was to identify risk factors
ssociated with 30-day perioperative mortality after elective
PG. This risk model was then validated and used to develop
risk calculator that can be used to estimate a patient’s risk of
0-day perioperative mortality after an elective BPG. This
alculator is anticipated to aid in surgical decision making,
nformed patient consent, preoperative optimization, and risk
eduction.
ETHODS
Data set. Data were extracted from the 2007, 2008,
nd 2009 NSQIP Participant Use Data Files (PUF).5 These
re multicenter, prospective databases with 183 (year
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Volume 56, Number 2 Gupta et al 3732007), 211 (year 2008), and 237 (year 2009) participant
academic and community U.S. hospitals, with data being
collected on 136 perioperative variables. In NSQIP, a
participating hospital’s surgical clinical nurse reviewer
(SCNR) captures data using a variety of methods, one of
which is medical record abstraction. The data are collected
based on strict criteria formulated by a committee. To
ensure the data collected are of a high quality, the NSQIP
has developed different training mechanisms for the SCNR
and conducts an inter-rater reliability audit of participating
sites.5 Inter-rater reliability audits show that overall dis-
agreement rates on variables were 1.56% in 2008.6 The
processes of SCNR training, inter-rater reliability auditing,
data collection, and sampling methodology have been pre-
viously described in detail.5,7,8
Patients. Patients undergoing elective BPG in the
NSQIP data sets were identified using the American Med-
ical Association’s Current Procedural Terminology (CPT)
codes for the procedures: 35556, 35566, 35571, 35583,
35585, 35587, 35656, and 35666 (Table I). Patients with
composite grafts (vein and prostheses) and femoral-femoral
bypasses were excluded. Preoperative data obtained in-
cluded demographic, lifestyle, comorbidity, and other vari-
ables. The list of variables extracted is mentioned in the
Appendix (online only). Patients who underwent other
operations in the 30 days before the index operation were
excluded.
Definitions. Preoperative functional status has been
defined in the NSQIP as the ability to perform activities of
daily living in the 30 days before surgery and has been
classified as independent, partially dependent, and totally
dependent. Activities of daily living are defined as the
activities usually performed in the course of a normal day in
a person’s life and include bathing, feeding, dressing, toi-
leting, and mobility.
Systemic inflammatory response syndrome (SIRS) is
clinically recognized by the presence of two or more of the
Table I. American Medical Association’s Current
Procedural Terminology (CPT) codes for infrainguinal
bypass graft operations
CPT code Description
35556 Bypass graft with vein, femoral-popliteal
35566 Bypass graft with vein, femoral-anterior tibial,
posterior tibial, peroneal artery or other distal
vessels
35571 Bypass graft with vein, popliteal-tibial, peroneal or
other distal vessels
35583 In situ vein bypass; femoral-popliteal
35585 In situ vein bypass; femoral-anterior tibial,
posterior tibial, or peroneal artery
35587 In situ vein bypass; popliteal-tibial, peroneal artery
35656 Bypass graft with other than vein; femoral-
popliteal
35666 Bypass graft with other than vein; femoral-anterior
tibial, posterior tibial, or peroneal arteryfollowing 48 hours before surgery: temperature 38°C pr36°C; heart rate90 beats/min; respiratory rate20
reaths/min or partial pressure of arterial CO2 32 mm
g (4.3 kPa); white blood cell count 12,000 cell/
m3, 4000 cells/mm3, or 10% immature (band)
orms; anion gap acidosis defined as [Na  K] – [CL 
CO3 (or serum CO2)] 16 or Na – [CL  HCO3 (or
erum CO2)] 12.
Outcome. The primary outcome of interest was peri-
perative mortality. Other outcomes that were analyzed
ncluded hospital length of stay, minor morbidity (urinary
ract infection or superficial wound infection), and major
orbidity. The latter included deep wound infection, or-
an space infection, wound dehiscence, pneumonia, rein-
ubation, ventilator requirement 48 hours, pulmonary
mbolus, deep venous thrombosis, renal insufficiency,
cute renal failure, stroke, coma, peripheral nerve defi-
iency, graft/prosthesis failure, cardiac arrest, myocardial
nfarction, transfusion4 units packed red blood cells72
ours, sepsis, septic shock, or return to the operating room.
he NSQIP database captures outcomes through 30 days
fter surgery, except for hospital length of stay, which is
ecorded until the patient is discharged.
Statistical analysis. Univariate exploratory analysis
as performed on the 2007 to 2009 NSQIP data sets.
earson 2 test or Fisher exact test were used to analyze
ategoric variables, and t or F tests were used for continu-
us variables. Stepwise multivariable logistic regression
nalysis was used to identify preoperative variables associ-
ted with increased risk of mortality30 days of an elective
PG. A Bayes information criterion vs model size plot was
reated to determine the number of variables in the “final”
arsimonious model, with the model with seven variables
iving the lowest Bayes information criterion. All of the
bove-mentioned preoperative variables, including CPT
urgical code, were controlled for in the multivariate
nalysis.
Categoric predictors such as race were incorporated
nto the model using reference coding. This means that one
evel of the categoric predictor is chosen as a reference
ategory, and the remaining levels of the predictor are
ompared to the reference. Statistical analysis was per-
ormed using SAS 9.2 software (SAS Institute, Cary, NC).
value of P  .05 was considered significant.
Riskmodel performance. The accuracy of the logistic
egression model was assessed by its discrimination and
alibration.9 Discrimination measures how well a model
an distinguish between cases (mortality) vs noncases (sur-
ival). Discrimination was assessed by C statistic, also
nown as area under the receiver operating characteristic
urve. The C statistic ranges from 0.50 (no better than
ipping a coin) to 1.00 (model is 100% correct).
Calibration measures a model’s ability to generate pre-
ictions that are close to the observed outcomes in the data.
he most widely used method for doing this for hospital-
ased mortality models is the Hosmer-Lemeshow test,
hich examines how well the percentage of observed death
atches the percentage of predicted death over deciles ofredicted risk.9
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August 2012374 Gupta et alRisk model validation. Because predictive models
perform better in the data from which they were derived
than on new data, we performed bootstrap resampling to
obtain a bias-corrected C statistic, thereby providing a
more accurate estimate of model performance in other
populations.10 This method of internal validation was cho-
sen over others, such as split-sample modeling, because
bootstrap resampling techniques have been shown to pro-
duce stable and nearly unbiased estimates of predictive
accuracy with better efficiency than other methods.10 For
this purpose, 1000 random bootstrap samples with replace-
ment, and of the same size as the original sample, were
drawn from the original data set consisting of all patients.
Development of risk calculator. Once the model was
validated, it was used to develop a risk calculator, which
takes the form of an interactive spreadsheet that accepts
patient covariate information and returns the estimated
probability percentage of perioperative mortality based on
the validated model. Alternatively, one can generate this
estimated probability percentage using the model fit di-
rectly as described in detail previously.11 The parameter
estimates and standard errors for the model are presented in
the Results section. These estimated coefficients can be
used to estimate the logit (L^) for a patient using the stan-
dard binary logistic regression equation. The estimated
probability percentage of mortality for a patient is then
computed using the following formula:
estimated probability  100% *
eL^
1 eL^
RESULTS
Demographics and univariate analyses. In the 2007
to 2009 data set, 9556 patients underwent elective BPG.
The data set comprised 6106 men (63.9%) and 3449
women (36.1%), with a median (lower quartile-upper quar-
tile) age of 68 years (range, 60-77 years).
The 30-day perioperative mortality rate was 1.8% (n 
170), which included two intraoperative deaths. The major
morbidity rate was 22.8%. Fifteen percent (n  1439) of
the patients had to be taken back to the operating room
30 days. Median (lower quartile-upper quartile) length of
hospital stay was 4 days (range, 3-7 days). Demographic
characteristics, preoperative risk factors, and laboratory val-
ues are listed in Table II. Postoperative complications are
listed in Table III.
Multivariable logistic regression analysis. Preop-
erative variables significantly associated with a higher
perioperative mortality included age, SIRS, chronic corti-
costeroid use, chronic obstructive pulmonary disease
(COPD), dependent functional status, dialysis depen-
dence, and rest pain in lower extremity (Table IV).
Analysis of risk factors. Of 532 patients on preoper-
ative dialysis, 42 (7.9%) died 30 days of surgery in con-
trast to 128 deaths among 9024 patients (1.4%) not on
dialysis. Among the 170 patients who died 30 days of iurgery, 24.7% (n  42) were dialysis-dependent in con-
rast to 5.2% of survivors (P  .0001).
Of 1376 dependent patients, 68 (4.9%) died 30 days
f surgery in contrast to 102 deaths among 8180 indepen-
ent patients (1.2%). Among the 170 patients who died
30 days of surgery, 40.0% (n  68) had a dependent
unctional status before surgery in contrast to 13.9% of
urvivors (P  .0001).
Of 263 patients with preoperative SIRS, 23 (8.7%) died
30 days of surgery in contrast to 147 deaths among 9293
atients (1.6%) without SIRS. Among the 170 patients
ho died30 days of surgery, 13.5% (n 23) had preop-
rative SIRS in contrast to 2.6% of the survivor cohort (P
0001).
Of 348 patients on chronic corticosteroids, 20 (5.7%)
ied30 days of surgery, which contrasts with 150 deaths
mong 9208 (1.6%) nonsteroid users. Among the 170
atients who died 30 days of surgery, 11.8% (n  20)
sed corticosteroids chronically in contrast to 3.5% of sur-
ivors (P  .0001). Patients who took oral or parenteral
orticosteroid medications for 10 days in the 30 days
efore surgery for a chronic medical condition (eg, COPD,
sthma, rheumatologic disease, rheumatoid arthritis, in-
ammatory bowel disease) were considered in this cate-
ory. Topical corticosteroids applied to the skin or cortico-
teroids administered by inhalation or rectally were not
ncluded.
Of 1217 patients with COPD, 41 (3.4%) died 30
ays of surgery in contrast to 129 deaths among 8339
atients (1.5%) without COPD. Among the 170 patients
ho died30 days of surgery, 24.1% (n 41) had COPD
n contrast to 12.5% of the survivor cohort (P  .0001).
ighty-five patients with COPD were taking oral or paren-
eral corticosteroids, with 30-day mortality in this group
eing much higher (10.6%) than in other patients with
OPD.
Of 4453 patients with rest pain in the lower extremity,
17 (2.6%) died 30 days of surgery in contrast to 53
eaths among 5103 patients (1.0%) without rest pain.
mong the 170 patients who died 30 days of surgery,
8.8% (n  117) had rest pain in contrast to 46.2% of the
urvivor cohort (P  .0001).
The median (lower-upper quartile) age was 68 (range,
0-77) years among the survivors and 76.5 (range, 69-83)
ears among nonsurvivors (P .0001). Mortality doubled
ith every 12-year increase in age. Death 30 days of
urgery occurred in 32 of 3676 patients (0.9%) aged 65
ears in contrast with 42 of 3101 (1.4%) deaths in patients
ged between 65 and 74 years and 96 of 2779 (3.5%)
atients aged 75 years.
The risk model and calculator. The risk model in-
luded the factors significantly associated with 30-day mor-
ality from the 2007 to 2009 data set. The parameter
stimates and their standard errors are summarized in Table
V. The reference group for functional status was indepen-
ent functional status. Table IV can be used to generate
robability estimates identical to the risk calculator by
nserting the appropriate coefficient estimates into the stan-
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Volume 56, Number 2 Gupta et al 375ard logistic regression model to compute the estimated
ogit and then translating this logit into the probability
cale as described in the Methods section.
The model demonstrated excellent discrimination (C
tatistic, 0.81; bias-corrected C statistic, 0.81) and calibra-
ion (Hosmer-Lemeshow test 2  5.58; P  .69). The
alibration was excellent, without a substantial deviation
rom the 45° line of perfect fit (Fig).
The selected model was then used to develop a risk
alculator. In the risk calculator, values are entered as 0 and
for absence or presence, respectively, of SIRS, chronic
orticosteroid use, COPD, rest pain, and dialysis depen-
ence. Three categories are listed for functional status
independent, partially dependent, totally dependent),
nd age is a continuous value. When the required input is
ntered into this calculator for a given patient, it returns
model-based percentage estimate of perioperative mor-
ality.
We present a few examples of calculated postoperative
able II. Continued
ategory and preoperative variable
No. (%) or median
(LQ-UQ)
Partial thromboplastin time 1671 (17.5)
Serum glutamic oxaloacetic
transaminase 561 (5.9)
Sodium 1741 (18.2)
White blood cell count 1459 (15.3)
eurologic
Hemiplegia 263 (2.8)
Paraplegia 41 (0.4)
Stroke
With neurologic deficit 709 (7.4)
Without neurologic deficit 663 (6.9)
Transient ischemic attack 678 (7.1)
enal
Preoperative dialysis 532 (5.6)
espiratory
Chronic obstructive pulmonary disease 1217 (12.7)
Dyspnea
At rest 140 (1.5)
On moderate exertion 1548 (16.2)
Preoperative pneumonia 12 (0.1)
ocial
Alcohol intake within last 2 weeks 566 (5.9)
Smoking within past year 3987 (41.7)
herapy
Anesthesia
General 8438 (88.3)
Regional 1118 (11.7)
Current Procedural Terminology code
35556 2729 (28.6)
35566 1803 (18.9)
35570 10 (0.1)
35571 692 (7.2)
35583 580 (6.1)
35585 591 (6.2)
35587 75 (0.8)
35656 2400 (25.1)
35666 676 (7.1)Table II. Preoperative characteristics for the 2007 to
2009 National Surgical Quality Improvement Program
data set
Category and preoperative variable
No. (%) or median
(LQ-UQ)
Cardiac
Angina 1 month 173 (1.8)
Prior cardiac surgery 2352 (24.6)
Congestive heart failure 179 (1.9)
Myocardial infarction (6 months) 150 (1.6)
Prior percutaneous coronary
intervention 1798 (18.8)
Circulatory
Bleeding disorder 2138 (22.4)
Prior peripheral arterial revascularization
or amputation 5223 (54.7)
Rest pain in lower extremity 4453 (46.6)
Open wound 3353 (35.1)
General
Age, years 68 (60-77)
American Society of Anesthesiologists
class 259 (2.7)
1 2857 (29.9)
2
3 5242 (54.9)
4 1189 (12.5)
5 3 (0.03)
Body mass index, kg/m2 27.6 (24.2-31.7)
Chronic corticosteroid use 348 (3.6)
Diabetes mellitus
On insulin 2077 (21.7)
On medication 2023 (21.2)
Preoperative do not resuscitate order 81 (0.9)
Functional status
Partially dependent 1284 (13.4)
Totally dependent 92 (1.0)
Hypertension 8004 (83.8)
Race
American Indian 29 (0.3)
Asian/Pacific islander 97 (1.0)
Black 1460 (15.3)
Hispanic 405 (4.2)
Unknown 533 (5.6)
White 7032 (73.6)
Sex
Male 6106 (63.9)
Female 3449 (36.1)
Systemic inflammatory response
syndrome 263 (2.8)
Transition, admitted from:
Home 9074 (95.0)
Acute care 168 (1.8)
Veterans Administration acute care 11 (0.1)
Chronic care 266 (2.8)
Veterans Administration chronic care 1 (0.01)
Others 36 (0.4)
Weight loss 10% within 6 months 134 (1.4)
Abnormal laboratory values
Albumin 1623 (17.0)
Alkaline phosphatase 616 (6.5)
Bilirubin 121 (1.3)
Blood urea nitrogen 4379 (45.8)
Creatinine 1711 (17.9)
Hematocrit 3558 (37.2)
Platelets 1982 (20.7)ortality after an elective BPG using the risk calculator:
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August 2012376 Gupta et al1. A 60-year-old man, independent, not on preoperative
dialysis or corticosteroids, and without preoperative
SIRS, COPD, or lower extremity rest pain: 0.32%.
2. A 65-year-old woman, partially dependent, with
COPD, on preoperative dialysis but not corticosteroids,
and without preoperative SIRS or lower extremity rest
pain: 7.5%.
3. A 75-year-old man, independent, on preoperative dial-
ysis and chronic corticosteroids for COPD, but without
preoperative SIRS and lower extremity rest pain: 17.6%.
4. A 65-year-old man, independent, without COPD, not
on preoperative dialysis or corticosteroids, but with
preoperative SIRS and lower extremity rest pain: 3.0%.
5. A 65-year-old woman, totally dependent, on preop-
erative dialysis and corticosteroids for COPD, and
with preoperative SIRS and lower extremity rest pain:
Table III. Intraoperative and postoperative
characteristics for the 2007 to 2009 National Surgical
Quality Improvement Program data set
Variables Median (LQsUQ) or No. (%)
Intraoperative
Anesthesia time, minutes 273 (212-350)
Operative time, minutes 206 (153-276)
Postoperative
Major complications
Cardiac
Cardiac arrest 76 (0.8)
Myocardial infarction 141 (1.5)
PRBC transfusion 4 U 84 (0.9)
Graft/prosthesis failure 439 (4.6)
Infection
Sepsis 238 (2.5)
Septic shock 100 (1.1)
Neurologic
Coma 8 (0.1)
Nerve deficit 4 (0.04)
Stroke 51 (0.5)
Renal
Acute renal failure 35 (0.4)
Renal insufficiency 51 (0.5)
Respiratory
Pneumonia 119 (1.3)
Reintubation 135 (1.4)
Ventilator 48 hours 88 (0.9)
Return to operating room 1439 (15.1)
Venous thromboembolism
Deep venous thrombosis 66 (0.7)
Pulmonary embolism 17 (0.2)
Wound
Deep wound infection 227 (2.4)
Wound dehiscence 157 (1.6)
Any major morbidity 2181 (22.8)
Minor complications
Superficial wound infection 703 (7.4)
Urinary tract infection 162 (1.7)
Other postoperative parameters
LOS for survivors, days 4 (3-7)
Mortality 170 (1.8)
LOS, Length of stay; LQ, lower quartile; PRBC, packed red blood cells; UQ,
upper quartile.78.4%. cISCUSSION
Treatment options for patients with symptomatic PAD
nclude nonoperative management, endovascular or open
evascularization, and amputation. In addition to anatomic
nd lesion characteristics, patient clinical characteristics and
references, and operator expertise, the surgical decision
aking in patients with symptomatic PAD requires knowl-
dge of short-term perioperative risks and long-term AFS.
lthough the PIII risk score2,3 and BASIL prediction
odel4 help in assessing long-term AFS after BPG, there
re no reports in the literature of short-term perioperative
isk assessment tools for BPG. Further, the PIII risk score
nd BASIL prediction model had restrictive inclusion cri-
eria for the patients to enter their respective studies, result-
ng in a select cohort of patients who do not reflect the
eneral population of patients in everyday practice under-
oing BPG.
Using the ACS’ NSQIP database, our study identified
ge, SIRS, chronic corticosteroid use, COPD, dependent
unctional status, dialysis dependence, and rest pain in the
ower extremity as preoperative factors associated with
ortality 30 days of an elective BPG. Age has been
reviously identified as a significant risk factor for AFS in
he PIII and BASIL risk scores, besides other studies.3,4,12
t was interesting to note that perioperative mortality was
our times higher in patients aged 75 years (3.5%) com-
ared with patients aged 65 years (0.9%). Age thus ap-
ears to be an important predictor for short-term and
ong-term outcomes in patients undergoing BPG.
Renal function has also proven to be an important
rognostic marker in patients undergoing intervention for
ower extremity PAD. Dialysis dependence (PIII score) and
bnormal creatinine (BASIL model) are indicative of a poor
FS. It was striking that 24.7% of the deaths among the
able IV. Stepwise logistic regression analysis (2007-
009 National Surgical Quality Improvement Program
ata set)
ariable Estimatea SEa
Adjusted
OR
95% Wald
CI
ntercept 9.26 0.63
ncreasing age per year 0.06 0.01 1.06 1.04-1.08
hronic corticosteroid use 1.04 0.26 2.83 1.69-4.73
OPD 0.64 0.19 1.90 1.30-2.78
IRS 1.33 0.25 3.76 2.30-6.17
ialysis dependence 1.63 0.20 5.09 3.44-7.54
unctional status
Totally dependentb 1.47 0.39 4.33 2.03-9.22
Partially dependentb 0.66 0.18 1.93 1.36-2.75
ower extremity rest pain 0.63 0.17 1.89 1.34-2.66
I, Confidence interval; COPD, chronic obstructive pulmonary disease;
D, odds ratio; SIRS, systemic inflammatory response syndrome; SE, stan-
ard error.
The estimate and the SE refer to the estimate of the logistic regression
oefficient for the specific variable and its associated standard error. C
tatistic, 0.81.
Independent functional status is the reference group.urrent study population were in patients who were on
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Volume 56, Number 2 Gupta et al 377dialysis before surgery, in contrast to 5.2% prevalence in the
survivors. The high coprevalence of PAD and dialysis de-
pendence raises the issue of screening for PAD in patients
with impaired renal function.13
Dependent functional status as a variable was not eval-
uated in previous risk models. However, our group and
others have shown that it has a significant effect on postop-
erative outcomes.14-16 Although dependent patients com-
prised only 14.4% of our study population, 40.0% of deaths
after BPG were in this group of patients. The increased risk
for death in these groups is quite remarkable, with indepen-
dent patients having a short-term mortality rate of 1.2% in
contrast to 4.9% in partially and totally dependent patients.
A thorough risk-benefit analysis needs to be performed
before BPG in patients who are partially or totally depen-
dent with respect to their ability to perform their activities
of daily living.
Similar to functional status, chronic corticosteroid
therapy and COPD have not been evaluated in previous risk
models. Although patients on corticosteroids comprised
only 3.6% of the current study population, they had a 5.7%
mortality rate compared with 1.6% among patients not on
chronic corticosteroids. Patients with COPD who were
taking corticosteroids had even higher 30-day mortality
(10.6%), whereas other patients with COPD also had a
relatively higher 30-day mortality rate (3.4%). The indica-
tion for corticosteroid use is not mentioned in the NSQIP
database. Corticosteroids have previously been shown to be
associated with a higher risk for stroke after carotid endar-
terectomy,15 and another study of all surgical patients
showed a fourfold increase in mortality in patients taking
corticosteroids.17 These drugs have been shown to increase
cardiovascular events due to their atherogenic properties,
which could account for the higher risk seen in the present
study, or they could simply be a marker for an advanced
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The denotes deciles of patients.systemic disease.17 iPatients with preoperative SIRS had a significantly
igher mortality rate (8.7%) than patients without SIRS
1.6%), with SIRS being an independent risk factor for
erioperative death after BPG. Although the precise rea-
ons are not known, we speculate that SIRS is a reflection of
ystemic inflammation and poor homeostasis, which makes
erioperative adverse events after BPG more likely. That
IRS was present preoperatively in3% of the patients who
nderwent an elective BPG was not surprising. The defini-
ion of SIRS is based on the simultaneous presence of two
r more specific vital sign or laboratory parameters, which
akes it very likely that in actual clinical practice, its pres-
nce might go unrecognized in a patient who does not
look ill” overall. The association of preoperative SIRS with
erioperative death after BPG suggests that these patients
ay benefit from endovascular revascularization, with open
perations reserved only for patients failing endovascular
herapy and after resolution of SIRS.
It was not surprising to find that rest pain in lower
xtremities was associated with a higher risk of death after
PG. Approximately 45% of the study population had rest
ain, with a 30-day mortality 2.5 times higher than patients
ithout rest pain. Although not significant on multivariate
nalysis, an open wound was seen in 35% of the population
nd was associated with a three times higher 30-day mor-
ality. Previous studies have shown that tissue loss and the
ollinger angiogram score were risk factors for AFS.3,4
hese findings thus suggest a higher perioperative risk in
atients with relatively advanced PAD.
Recent myocardial infarction, congestive heart failure,
nd diabetes were not associated with perioperative death
fter BPG. We have previously shown that these comor-
idities are not independently associated with cardiac
vents after vascular surgery.18 Our data demonstrate that
hese parameters are not predictive of perioperative death
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tality after BPG independent of dialysis dependence.3 On
the basis of these findings, future studies may reconsider the
value of routine preoperative cardiac evaluation in patients
scheduled to undergo BPG, especially when they are not
elderly and do not have any of the higher-risk parameters of
SIRS, chronic corticosteroid use, COPD, dependent func-
tional status, dialysis dependence, and rest pain. The risk
calculator presented in this study is anticipated to be an aid
to the clinician’s judgment on the need for preoperative
cardiac and pulmonary evaluation.
The PIII and BASIL risk scores were developed to
assess long-term AFS after BPG and differ from the current
risk calculator because their patients were drawn from a
randomized trial with strict inclusion criteria, thus limiting
generalizability. Further, due to the use of Kaplan-Meier
and Cox regression survival analysis to include all patients,
validation of the PIII risk score was subjective and without
a rigorous analysis in the form of receiver operator curves
with an associated C statistic.
The BPG risk calculator presented in the current study
was developed to aid in the surgical decision making and
informed consent process by complementing the existing
risk scores for AFS. It is in the form of an interactive
spreadsheet that is available as a free download at http://
www.surgicalriskcalculator.com/infrainguinalbypass-risk-
calculator. When the required input is entered into this
calculator for a given patient, it returns a model-based
percentage estimate of the patient’s perioperative 30-day
mortality. The bias-corrected C statistic of the risk model in
this study was 0.81 and thus has genuine clinical util-
ity.19,20
We chose to develop the risk calculator based on the
logistic regression model to directly predict patient mortal-
ity rather than as a point-based scoring system. A point-
based scoring system is less accurate because a separate
model is necessary for risk prediction, which is not the case
with our risk calculator. Further, with our risk calculator, an
exact model-based estimate of mortality probability is pro-
vided for a patient instead of classifying the patient as high
risk, intermediate risk, or low risk for perioperative death.
This approach is more precise than a point system but
may be more complex for some users to implement. As
clinicians take advantage of new, handheld, computer-
based technologies to access pharmacopeias and clinical
management guidelines, we believe that the risk calcula-
tor will find widespread use and assist surgeons in making
clinical decisions.
Although some of the clinical entities identified
through this model (such as age and dialysis dependence)
cannot be altered, several (such as SIRS, chronic steroid
use, functional status, and COPD) may be amenable to
preoperative intervention or optimization that could possi-
bly improve outcomes in patients undergoing BPG. Apart
from identifying high-risk patients and attempting to opti-
mize their clinical condition before an operation, we fore-
see the risk calculator as an important tool in the informed
consent process. Accurate individualized assessment of Werioperative risk after BPG would certainly assist in the
resentation of adequate information about risks and ben-
fits. Physicians have long quoted the most current litera-
ure to explain risks of adverse outcomes associated with a
rocedure. This has not always been an easy task because
ach patient has a unique set of risk factors. Thus, this risk
alculator will simplify the informed consent process by
roviding an estimate of perioperative mortality risk after
PG.
The present study has certain limitations. This study is
retrospective analysis of prospectively recorded data. Vari-
bles analyzed were limited to those recorded by NSQIP.
espite the data set being fairly comprehensive with 50
reoperative variables, information on arrhythmia and re-
ults of preoperative stress tests, echocardiography, and
lectrocardiography were not available, nor was anatomic
ata such as vessel diameter or amount of calcification.
ecause procedure extraction from the data set is based on
PT codes, we do not know how many of the BPGs were
evision procedures. Information on -blocker use was not
part of the data set; however, this has not been significant
n previous indices.
This risk calculator is only applicable for 30-day post-
perative mortality, with NSQIP not recording outcomes
30 days. Hospital and surgeon volumes were also not
vailable.
Lastly, patients with certain comorbidities may have
lready been pre-excluded from undergoing a BPG due to
resumed high risk, thus creating a sampling bias. How-
ver, this bias exists for all risk estimation tools21,22 because
hese tools are based on a sample of patients who have
lready undergone surgery and might have had exclusions
or presumed high risk.
ONCLUSIONS
Perioperative 30-day mortality after elective BPG was
.8% and increased significantly in patients with increasing
ge, SIRS, chronic corticosteroid use, COPD, dependent
unctional status, dialysis dependence, and lower extremity
est pain. We have demonstrated that a seven-variable vali-
ated risk calculator can be used to predict the risk of 30-day
ortality in individual patients undergoing infrainguinal by-
ass surgery, which is useful for patient counseling and for
uality assurance purposes. The calculator can also be used to
dentify patients at increased postoperative risk who, there-
ore, would benefit from preoperative optimization and con-
ideration of alternative therapies, including nonoperative
reatment and endovascular revascularization.
The risk calculator is available for download at: http://
ww.surgicalriskcalculator.com/infrainguinalbypass-
iskcalculator.
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The demographic variables analyzed included age, sex,
and race. Lifestyle variables studied included smoking (1
year of surgery) and alcohol (2 drinks daily in the 2 weeks
before surgery). Comorbidities studied included presence
or absence of renal disease (dialysis dependence), coronary
artery disease (angina 30 days of surgery, myocardial
infarction6 months of surgery, prior percutaneous coro-
nary intervention, and prior cardiac surgery), congestive
heart failure, hypertension, rest leg pain, pulmonary disease
(history of chronic obstructive pulmonary disease and pre-
existing pneumonia), neurologic event or disease (stroke
with or without residual deficit, transient ischemic attack,
hemiplegia, and paraplegia), diabetes mellitus, chronic cor-
ticosteroid use, weight loss (10% in the 6 months before
surgery), bleeding disorders, and open wound. Other fac-
tors considered were American Society of Anesthesiologists
class, admission status from home vs a facility, preoperativeunctional status, dyspnea (none, moderate exertion, at
est), preoperative do not resuscitate status, presence of
ystemic inflammatory response syndrome, and body mass
ndex. Complete definitions for all the above-listed vari-
bles have been previously published elsewhere.1
Preoperative laboratory variables analyzed included
lood urea nitrogen, creatinine, albumin, bilirubin, hemat-
crit, platelet count, serum glutamic oxaloacetic transami-
ase, white blood cell count, partial thromboplastin time,
nd prothrombin time. National Surgical Quality Improve-
ent Program definitions of normal and abnormal were
sed to categorize laboratory values as normal and abnor-
al: missing data constituted a third categoric level, an
ndicator variable.
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